Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jan 21;42(2):485-96.
doi: 10.1039/c2cs35348b.

The significance of acid/base properties in drug discovery

Affiliations
Review

The significance of acid/base properties in drug discovery

David T Manallack et al. Chem Soc Rev. .

Abstract

While drug discovery scientists take heed of various guidelines concerning drug-like character, the influence of acid/base properties often remains under-scrutinised. Ionisation constants (pK(a) values) are fundamental to the variability of the biopharmaceutical characteristics of drugs and to underlying parameters such as logD and solubility. pK(a) values affect physicochemical properties such as aqueous solubility, which in turn influences drug formulation approaches. More importantly, absorption, distribution, metabolism, excretion and toxicity (ADMET) are profoundly affected by the charge state of compounds under varying pH conditions. Consideration of pK(a) values in conjunction with other molecular properties is of great significance and has the potential to be used to further improve the efficiency of drug discovery. Given the recent low annual output of new drugs from pharmaceutical companies, this review will provide a timely reminder of an important molecular property that influences clinical success.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The drug discovery process.
Figure 2
Figure 2
Diagram illustrating the key properties that are influenced by the acid/base character of drugs. Each node highlights an important facet of drug discovery and development.
Figure 3
Figure 3
(A), Proportion of compound categories for ionisable oral drugs. (B), pKa distributions of oral drugs containing a single acidic functional group, or (C) single basic functional group. Compounds with the following criteria were classified as always ionised: acids with pKa values < 0 and bases with pKa values > 12, plus compounds with permanently charged groups (e.g., quaternary nitrogen atoms). Acids with pKa values above 10 or bases with pKa values below 0.0 were considered neutral. The remaining ionisable compounds (acid pKa range 0-10 and base pKa range 0-12) were divided into the following groups: single acid-containing substances, single base-containing substances, compounds with two acidic groups, compounds with two basic groups, simple ampholytes (one acidic and one basic group) and other complex combinations of acidic and basic groups (complex ampholytes). pKa values were binned into single log unit ranges (i.e. 0.0 < X ≤ 1.0, 1.0 < X ≤ 2.0, etc.). The histogram column heights are expressed as a percentage.
Figure 3
Figure 3
(A), Proportion of compound categories for ionisable oral drugs. (B), pKa distributions of oral drugs containing a single acidic functional group, or (C) single basic functional group. Compounds with the following criteria were classified as always ionised: acids with pKa values < 0 and bases with pKa values > 12, plus compounds with permanently charged groups (e.g., quaternary nitrogen atoms). Acids with pKa values above 10 or bases with pKa values below 0.0 were considered neutral. The remaining ionisable compounds (acid pKa range 0-10 and base pKa range 0-12) were divided into the following groups: single acid-containing substances, single base-containing substances, compounds with two acidic groups, compounds with two basic groups, simple ampholytes (one acidic and one basic group) and other complex combinations of acidic and basic groups (complex ampholytes). pKa values were binned into single log unit ranges (i.e. 0.0 < X ≤ 1.0, 1.0 < X ≤ 2.0, etc.). The histogram column heights are expressed as a percentage.
Figure 3
Figure 3
(A), Proportion of compound categories for ionisable oral drugs. (B), pKa distributions of oral drugs containing a single acidic functional group, or (C) single basic functional group. Compounds with the following criteria were classified as always ionised: acids with pKa values < 0 and bases with pKa values > 12, plus compounds with permanently charged groups (e.g., quaternary nitrogen atoms). Acids with pKa values above 10 or bases with pKa values below 0.0 were considered neutral. The remaining ionisable compounds (acid pKa range 0-10 and base pKa range 0-12) were divided into the following groups: single acid-containing substances, single base-containing substances, compounds with two acidic groups, compounds with two basic groups, simple ampholytes (one acidic and one basic group) and other complex combinations of acidic and basic groups (complex ampholytes). pKa values were binned into single log unit ranges (i.e. 0.0 < X ≤ 1.0, 1.0 < X ≤ 2.0, etc.). The histogram column heights are expressed as a percentage.
None
Plot showing the % protonated species against pH for a compound with a single acidic group (pKa 4.0).
None
Plot showing the % protonated species against pH for a compound with a single basic group (p Ka 9.0).

References

    1. Meanwell NA. Chem Res Toxicol. 2011;24:1420–1456. - PubMed
    1. Leeson PD, St-Gallay SA. Nat Rev Drug Discov. 2011;10:749–765. - PubMed
    1. Hann MM. Med Chem Commun. 2011;2:349–355.
    1. Gleeson MP. J Med Chem. 2008;51:817–834. - PubMed
    1. Gleeson MP, Hersey A, Montanari D, Overington J. Nat Rev Drug Discov. 2011;10:197–208. - PMC - PubMed

Publication types

Substances